tiprankstipranks
Medicenna Therapeutics Corp (TSE:MDNA)
TSX:MDNA

Medicenna Therapeutics Corp (MDNA) Financial Statements

133 Followers

Medicenna Therapeutics Corp Financial Overview

Medicenna Therapeutics Corp's market cap is currently ―. The company's EPS TTM is C$-0.221; its P/E ratio is -7.61; Medicenna Therapeutics Corp is scheduled to report earnings on June 26, 2024, and the estimated EPS forecast is C$-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -4.98MC$ -3.72MC$ -2.86MC$ -3.20MC$ -1.14M
EBITDAC$ -4.98MC$ -3.72MC$ -2.86MC$ -3.20MC$ -1.14M
Net Income Common StockholdersC$ -4.98MC$ -3.72MC$ -2.86MC$ -3.86MC$ -1.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 21.76MC$ 25.69MC$ 29.61MC$ 33.60MC$ 36.15M
Total AssetsC$ 23.27MC$ 27.74MC$ 31.55MC$ 36.45MC$ 38.17M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -21.76MC$ -25.69MC$ -29.61MC$ -33.60MC$ -36.15M
Total LiabilitiesC$ 4.64MC$ 4.31MC$ 4.65MC$ 6.96MC$ 4.95M
Stockholders EquityC$ 18.63MC$ 23.44MC$ 26.90MC$ 29.49MC$ 33.23M
Cash Flow-
Free Cash Flow-C$ -3.92MC$ -3.47MC$ -2.29MC$ -3.66M
Operating Cash FlowC$ -4.03MC$ -3.92MC$ -3.47MC$ -2.29MC$ -3.66M
Investing Cash Flow-----
Financing Cash FlowC$ 3.00K--C$ -189.00KC$ 136.00K
Currency in CAD

Medicenna Therapeutics Corp Earnings and Revenue History

Medicenna Therapeutics Corp Debt to Assets

Medicenna Therapeutics Corp Cash Flow

Medicenna Therapeutics Corp Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis